Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Spokane
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Spokane, WA

Studies commonly pay $75 to $4,500 per completed study

292 clinical trials are currently recruiting participants within 30 miles of Spokane. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

292studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Spokane right now

Top 25 of 292 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Medical Oncology Associates /ID# 247003 — Spokane, Washington (0.5 mi) · Sponsor: AbbVie

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Alcohol Use Disorder (AUD), Nicotine Use Disorder Phase 2 Interventional 205 participants sought
Washington State University — Spokane, Washington (0.5 mi) · Sponsor: Washington State University

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Cancer Care Northwest ( Site 0003) — Spokane, Washington (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Spokane, Washington (0.5 mi) · Sponsor: Daiichi Sankyo

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Deaconess Hospital — Spokane, Washington (0.5 mi) · Sponsor: Eli Lilly and Company

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 3 Interventional 804 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: NRG Oncology

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Spokane, Washington (0.5 mi) · Sponsor: Sameek Roychowdhury

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC Phase 1 Interventional 170 participants sought
ALX Center 1 — Spokane, Washington (0.5 mi) · Sponsor: ALX Oncology Inc.

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: NRG Oncology

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology

ERP to Improve Functioning in Veterans With OCD

Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD N/A Interventional 160 participants sought
Spokane VA Medical Center, Spokane, WA — Spokane, Washington (0.5 mi) · Sponsor: VA Office of Research and Development

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Solid Tumor, Biliary Tract Cancer Phase 1, Phase 2 Interventional 140 participants sought
Medical Oncology — Spokane, Washington (0.5 mi) · Sponsor: TiumBio Co., Ltd.

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Heart Failure, Acute Heart Failure Phase 3 Interventional 5,200 participants sought
Spokane, WA Investigative Site 10123 — Spokane, Washington (0.5 mi) · Sponsor: Colorado Prevention Center

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Phase 2 Interventional 48 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: SWOG Cancer Research Network

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer Phase 3 Interventional 1,514 participants sought
Medical Oncology Associates — Spokane, Washington (0.5 mi) · Sponsor: Gilead Sciences

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 1,088 participants sought
Arthritis Northwest, PLLC | Spokane, WA — Spokane, Washington (0.5 mi) · Sponsor: Takeda

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis Phase 3 Interventional 366 participants sought
Local Institution - 0264 — Spokane, Washington (0.5 mi) · Sponsor: Bristol-Myers Squibb
Actively enrolling

Studies you may be able to join near Spokane

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Spokane

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Inland Northwest Research

★ 5.0
610 S Sherman St Ste 208, Spokane, WA 99202
(509) 960-2818

Premier Clinical Research

★ 5.0
324 S Sherman St, Spokane, WA 99202
(509) 343-3710

Providence Medical Research Center

★ 5.0
105 W 8th Ave Ste 250E, Spokane, WA 99204
(509) 474-4345
"I dont know will see after my appointment today"
— Terry A, 5★

Citta Clinical Research

251 E 5th Ave Ste a, Spokane, WA 99202
(509) 816-1819

Principle Research Solutions

510 S Cowley St, Spokane, WA 99202
(509) 474-1107

WSU Spokane Center for Clinical Research and Simulation (CCRS)

410 North Sherman Street, Spokane, WA 99202
(509) 358-7500

WSU APPL & PRISM Research Clinics

★ 5.0
225 E 3rd Ave, Spokane, WA 99202
(509) 638-2376
"The people who work there are so caring & friendly.<br>I always look forward to visiting them."
— Michael K., 5★

Strategic Research Associates

★ 3.8
29 W Pacific Ave, Spokane, WA 99201
(888) 554-6960
"I have received texts occasionally for the last 10 years that I’m “qualified” for one of their surveys/programs. I’ve filled out 20+ questionnaires t…"
— Morgan Ireland, 1★

Velocity Clinical Research

★ 5.0
9921 N Nevada St Ste 200, Spokane, WA 99218
(509) 505-6227
"The staff is always awesome as well as my experience with the clinical trials. Down 26 pounds in just a few months. Not been this weight since just …"
— Rebecca Williams, 5★

Clinical trials in Spokane: what's recruiting

The Spokane area currently has 292 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Spokane, the most active research areas are:

  • Cancer & Oncology13 studies
  • Immune & Skin2 studies
  • Brain & Mental Health1 studies
  • Liver & Kidney1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Spokane, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Spokane

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Spokane participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Spokane pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Spokane?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Spokane safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Spokane, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Spokane?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Spokane.

Paid clinical trials near Spokane

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of WA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts